Curtain down for Baucus – and also for US device tax?
This article was originally published in Clinica
Executive Summary
The retirement of US health reform co-architect Max Baucus from the Senate, to take effect at the close of the current senate session (his sixth), has prompted much speculation about the 2.3% tax on US medical device sales, and indeed the wider 2010 US healthcare reform.